The National Pharmaceutical Pricing Authority (“NPPA”), vide an office memorandum dated August 25,2017, has provided a clarification with respect to the ceiling prices of orthopaedic knee implants as mentioned in a notification dated August 16th, 2017 (in the trail email). It has been clarified that the prices mentioned in the said notification are inclusive of Bone Cement component of the knee replacement and also of the cost of the instruments which are reusable and supplied free by the manufacturers to the distributors or hospitals.
In addition to this clarification, NPPA has also issued directions to all manufactures, importers, distributors, stockists of orthopaedic knee implant system and hospitals, nursing homes, clinics to display the price list at a conspicuous place. These parties are required to provide the following information, within August 30, 2017, on the home page of their website:-
(i) MRP or Price of Knee Implant System at which patients are being charged
(ii) Brand name of the Knee Implant System
(iii) Specifications of the Knee Implant System
(iv) Names of manufacturing company and the marketing company.
Failure to adhere with the above instructions will result in prosecution under the Essential Commodities Act, 1995 in addition to those under the Drugs Prices Control Order, 2013.
Source: National Pharmaceutical Pricing Authority